The WV Lung Cancer CareLine is operated by Patient Advocate Foundation in partnership with the WV Lung Cancer Project. This program is part of the MedCareLine Case Management division, an extension of PAF Case Management that focuses on certain health conditions, treatments, or groups of people.
About Patient Advocate Foundation
Patient Advocate Foundation (PAF) is a national 501 (c)(3) non-profit organization which provides professional case management services to patients with chronic, life threatening and debilitating diseases.
Established in 1996, Patient Advocate Foundation assists patients who have been diagnosed with serious illness overcome healthcare access barriers. PAF provides in-depth assistance through personalized case management, financial support, and connection to critical community resources. PAF serves uninsured and insured patients across the country at no charge to help overcome and resolve insurance-related and financial obstacles that impact care.
Patient Advocate Foundation has been consecutively recognized as a 4-star charity by Charity Navigator, the country’s premier independent charity evaluator. For more information about Patient Advocate Foundation visit www.patientadvocate.org.
About the WV Lung Cancer Project
The WV Lung Cancer Project seeks to decrease lung cancer mortality and improve the early diagnosis rate of lung cancer among Medicaid Managed Care beneficiaries and high risk populations across West Virginia.
The project is designed to: 1) build awareness of and support for lung cancer screening and 2) link patients with lung cancer to case management support to facilitate access to treatment and navigate financial and/or social barriers to care. The WV Lung Cancer Project is a collaboration among academia, lung cancer serving non-profits, community and healthcare stakeholders, all with the goal of impacting the leading cause of death in West Virginia, lung cancer.
This Project is made possible by the generous support of the Bristol-Myers Squibb Foundation – Bridging Cancer CareTM initiative as a part of the Foundation’s national strategy to reduce the burden of lung cancer among underserved populations.